scholarly article | Q13442814 |
P8978 | DBLP publication ID | journals/nature/WeydenACBWGVTSK17 |
P6179 | Dimensions Publication ID | 1038015702 |
P356 | DOI | 10.1038/NATURE20792 |
P932 | PMC publication ID | 5603286 |
P698 | PubMed publication ID | 28052056 |
P50 | author | Sarah Spiegel | Q20950329 |
Natasha A Karp | Q30511243 | ||
Iain C Macaulay | Q42317797 | ||
Tobias Bald | Q43117864 | ||
Anneliese O Speak | Q46442616 | ||
Thierry Voet | Q91106775 | ||
P2093 | author name string | Mark J Arends | |
David J Adams | |||
Simon Clare | |||
Antonella Galli | |||
Elizabeth Tuck | |||
Diane Gleeson | |||
Kim Wong | |||
Thomas Tüting | |||
Edward Ryder | |||
Louise van der Weyden | |||
Hannah Wardle-Jones | |||
Sanger Mouse Genetics Project | |||
Andrew D Campbell | |||
Emma L Cambridge | |||
Martin Del Castillo Velasco-Herrera | |||
Nicola Griggs | |||
P2860 | cites work | Bioconductor: open software development for computational biology and bioinformatics | Q21194861 |
Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis | Q24529958 | ||
Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes | Q24597048 | ||
The role of sphingosine-1-phosphate transporter Spns2 in immune system function | Q24599540 | ||
The role of sphingosine-1-phosphate in endothelial barrier function | Q26862336 | ||
Export of sphingosine-1-phosphate and cancer progression | Q27009557 | ||
Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond | Q27011857 | ||
PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells | Q28243975 | ||
IRF-7 is the master regulator of type-I interferon-dependent immune responses | Q28511410 | ||
Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice | Q28512818 | ||
The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice | Q28588851 | ||
Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network | Q28591658 | ||
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement | Q28594711 | ||
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research | Q29547313 | ||
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 | Q29547403 | ||
HTSeq--a Python framework to work with high-throughput sequencing data | Q29614489 | ||
STAR: ultrafast universal RNA-seq aligner | Q29615052 | ||
Microenvironmental regulation of tumor progression and metastasis | Q29615504 | ||
Integrative data analysis: the simultaneous analysis of multiple data sets | Q33457534 | ||
Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning | Q33615222 | ||
Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. | Q33773569 | ||
CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice | Q34091467 | ||
The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. | Q34217756 | ||
P-Rex1 is required for efficient melanoblast migration and melanoma metastasis | Q34235334 | ||
Critical steps in hematogenous metastasis: an overview. | Q34267607 | ||
Full-length RNA-seq from single cells using Smart-seq2. | Q34395363 | ||
Impact of temporal variation on design and analysis of mouse knockout phenotyping studies | Q34401154 | ||
Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease. | Q34628001 | ||
Smart-seq2 for sensitive full-length transcriptome profiling in single cells. | Q34993864 | ||
Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer | Q35144029 | ||
The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells | Q35221860 | ||
Spontaneous mutation of the Dock2 gene in Irf5-/- mice complicates interpretation of type I interferon production and antibody responses | Q35889350 | ||
Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp | Q36375152 | ||
Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis. | Q36386459 | ||
The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate | Q39589659 | ||
An improved Flp deleter mouse in C57Bl/6 based on Flpo recombinase | Q39699570 | ||
Antigen specificity determines the pro- or antitumoral nature of CD8+ T cells. | Q39763772 | ||
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages | Q40306295 | ||
Correction of Defects Responsible for Impaired Qa-2 Class Ib MHC Expression on Melanoma Cells Protects Mice from Tumor Growth | Q40653237 | ||
Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration | Q40900789 | ||
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene | Q46098688 | ||
Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients | Q46265539 | ||
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma | Q46279328 | ||
Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor | Q46927225 | ||
A sharper Bonferroni procedure for multiple tests of significance | Q56622251 | ||
p110γ and p110δ Phosphoinositide 3-Kinase Signaling Pathways Synergize to Control Development and Functions of Murine NK Cells | Q57184702 | ||
Requirement for IRF-1 in the microenvironment supporting development of natural killer cells | Q59098134 | ||
The sphingosine-1-phosphate receptor agonist FTY720 and its phosphorylated form affect the function of CD4+CD25+ T cells in vitro | Q84108192 | ||
P433 | issue | 7636 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 233-236 | |
P577 | publication date | 2017-01-04 | |
P1433 | published in | Nature | Q180445 |
P1476 | title | Genome-wide in vivo screen identifies novel host regulators of metastatic colonization | |
P478 | volume | 541 |